Gsk 2025 Full Year Results – GSK saw core operating profit jump in Q2 and won the latest round in its ongoing legal case, making the share price look even more undervalued to me. . GSK offers promising investment opportunities in healthcare industry despite economic uncertainties and risks. Read more on GSK stock here. .

Gsk 2025 Full Year Results

Source : www.gsk.com

GSK delivers 4% growth in Q2 revenue, ups full year guidance

Source : firstwordpharma.com

Events calendar | GSK

Source : www.gsk.com

EX 15.2

Source : www.sec.gov

GSK delivers strong 2023 performance and upgrades growth outlooks

Source : www.gsk.com

2023 Annual Report

Source : www.gsk.com

Annual Report 2023 | GSK

Source : www.gsk.com

GSK reports blockbuster sales RSV shot Arexvy in race vs. Pfizer

Source : www.fiercepharma.com

GSK’s experimental drug reduces asthma attacks in late stage trial

Source : qz.com

GSK nabs highly anticipated approval for RSV vaccine Arexvy

Source : www.fiercepharma.com

Gsk 2025 Full Year Results GSK delivers strong 2023 performance and upgrades growth outlooks : According to a report by KPMG, the economy of the UK is going through a combination of consumption tailwinds and falling inflation which is expected to support modest positive growth in the country . Specialty Medicines led the way with a 22% increase, bolstered by new oncology and HIV products. GSK’s overall sales were 5% ahead of consensus in the second quarter. Specialty medicines performed .